Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nademanee

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
Leukemia|November 28, 2012
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignanciesA M Vanderwalde, C-L Sun, L Laddaran, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host diseaseE P Smith, I Sniecinski, A C Dagis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remissionA Nademanee, A Molina, H Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective studyA Kashyap, F Kandeel, D Yamauchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2017
Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphomaA F Herrera, J Palmer, P Martin, et al.
Blood|February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factorsA Krishnan, S Bhatia, M L Slovak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Blood|November 14, 1997
Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk groupA Nademanee, A Molina, M R O'Donnell, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
Leukemia|November 28, 2012
Conditional survival and cause-specific mortality after autologous hematopoietic cell transplantation for hematological malignanciesA M Vanderwalde, C-L Sun, L Laddaran, et al.
Bone Marrow Transplantation|March 28, 2006
Maintenance thalidomide following single cycle autologous peripheral blood stem cell transplant in patients with multiple myelomaF Sahebi, R Spielberger, N M Kogut, et al.
Leukemia|July 29, 2000
High-dose cytosine arabinoside and daunorubicin induction therapy for adult patients with de novo non M3 acute myelogenous leukemia: impact of cytogenetics on achieving a complete remissionA S Stein, M R O'Donnell, M L Slovak, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|August 13, 1998
Extracorporeal photochemotherapy for treatment of drug-resistant graft-vs.-host diseaseE P Smith, I Sniecinski, A C Dagis, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 26, 1999
High-dose chemo/radiotherapy and autologous bone marrow or stem cell transplantation for poor-risk advanced-stage Hodgkin's disease during first partial or complete remissionA Nademanee, A Molina, H Fung, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 25, 2000
Effects of allogeneic bone marrow transplantation on recipient bone mineral density: A prospective studyA Kashyap, F Kandeel, D Yamauchi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 23, 2017
Autologous stem-cell transplantation after second-line brentuximab vedotin in relapsed or refractory Hodgkin lymphomaA F Herrera, J Palmer, P Martin, et al.
Blood|February 26, 2000
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factorsA Krishnan, S Bhatia, M L Slovak, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 1996
In vivo purging with high-dose cytarabine followed by high-dose chemoradiotherapy and reinfusion of unpurged bone marrow for adult acute myelogenous leukemia in first complete remissionA S Stein, M R O'Donnell, A Chai, et al.
Blood|November 14, 1997
Results of high-dose therapy and autologous bone marrow/stem cell transplantation during remission in poor-risk intermediate- and high-grade lymphoma: international index high and high-intermediate risk groupA Nademanee, A Molina, M R O'Donnell, et al.
Pageof 5